Alicia Logue, MD, associate professor, Department of Surgery, was interviewed for this episode of The Source.   Listen Now

A large, retrospective study conducted by scientists at the University of Texas at San Antonio (UT San Antonio) suggests that people taking glucagon-like peptide-1 (GLP-1) receptor agonists — medications that are widely prescribed for metabolic disease — have a significantly lower risk of developing colorectal cancer compared with those taking aspirin. “This is astounding to […]